Phase I/IIa Study of Genetically Engineered NY-ESO-1 SPEAR T-Cells Administered Following Autologous Stem Cell Transplant in HLA-a*02+ Patients with Advanced Multiple Myeloma: Long Term Follow-up (NCT01352286)

Autor: Rapoport, Aaron P., Stadtmauer, Edward A *, Chagin, Karen *, Faitg, Thomas *, Iyengar, Malini *, Trivedi, Trupti *, Norry, Elliot *, Holdich, Tom *, Binder-Scholl, Gwendolyn *, Amado, Rafael *, Fang, Frank *
Zdroj: In Blood 8 December 2017 130 Supplement 1:845-845
Databáze: ScienceDirect